Measurement of prostate-specific antigen by use of a novel blood collection and analytical system

Clinical Chemistry

Volumn 48, Issue 8, 2002, Pages 1272-1278

  Grzeda, Barbara R ^a   Le Bui, Tuan ^a   Warner, Cheryl N ^a   Pirucki, Tracy L ^a   Dewey, Lisa M ^a   Babich, Milan ^a   Maggiore, Jack A ^a  

^a BIOSAFE Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANALYTICAL EQUIPMENT; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CAPILLARY BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT MONITORING; PHLEBOTOMY; PROSTATE CANCER; VEIN PUNCTURE;

EID: 0036325648     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.8.1272     Document Type: Article

References (22)

1. Cancer statistics 2001
2. The role of increasing detection in the rising incidence of prostate cancer
3. Prevalence-corrected prostate cancer incidence rates and trends
4. Prostate-specific antigen: Advances and challenges
5. Conservative management of prostate cancer in the prostate specific antigen era: The incidence and time course of subsequent therapy
6. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening
7. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy
8. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate
9. Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring
10. Safety and efficacy of exisulind for treatment of recurrent prostate cancer after radical prostatectomy
11. PSA doubling time as a predicator of clinical progression after biochemical failure following radical prostatectomy for prostate cancer
12. Ultrasensitive time-resolved immunoflorometric assay of prostate-specific antigen in serum and preliminary clinical studies
13. Ultra-sensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the immulite immunochemiluminescent third-generation assay: Potential applications in prostate and breast cancers
14. Prostate-specific antigen comes of age in diagnosis and management of prostate cancer
15. Assay of prostate-specific antigen from whole blood spotted on filter paper and application to prostate cancer screening
16. Prostate-specific antigen: A cancer fighter and a valuable messenger?
17. Prostate specific antigen: A decade of discovery - What we have learned and where we are going
18. The value of serum prostate specific antigen determinations before and after radical prostatectomy
19. Prostate-specific antigen: Biochemistry, analytical methods, and clinical applications
20. Characterizations of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays
21. Electrochemical enzyme immunoassay for serum prostate-specific antigen at low concentrations